ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

RAS AL KHAIMAH, 20th November, 2025 (WAM) -- In the presence of H.H. Sheikh Mohammed bin Saud bin Saqr Al Qasimi, Crown Prince of Ras Al Khaimah, Ras Al Khaimah Economic Zone (RAKEZ) and Emerge, a ...

Roughly 13 minutes into “The Alabama Solution,” a revelatory new documentary about the long-simmering humanitarian crisis in Alabama’s state prisons, filmmakers Andrew Jarecki and Charlotte Kaufman ...

Note: This video is designed to help the teacher better understand the lesson and is NOT intended to be shown to students. It includes observations and conclusions that students are meant to make on ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

“The rearview mirror is smaller than the windshield for a reason.” “Today is the first day of the rest of your life.” These well-known things we say to our friends may sound cliché at times, but they ...

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. Baraka is perhaps the most interesting personality in a crowded Democratic primary to ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...

Ras Baraka, the Democratic mayor of Newark, New Jersey, and a candidate for governor, appeared in federal court Thursday for a status conference after being arrested at an ICE facility last week on a ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...